Maternal Abdominal Morphology Assessment
University of Texas at Austin · with National Institutes of Health (NIH) · NCT06784674
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–54 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 87
- US sites recruiting
- 1
- Study start
- May 6, 2025
- Record last updated
- October 22, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes.
The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.
Being studied: No intervention
Conditions: Pregnancy Related; Infant Development; Pancreas; Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Pregnant women, with a singleton gestation
- Age 18 - 54 years at screening
- Gestational age \< 14 weeks
- Willing to commit to 1 year postpartum follow up
- Planning to remain in geographical vicinity of Austin for 1 year after delivery
Exclusion Criteria
- Presence of any mechanically or magnetically activated implants
- Claustrophobia
- Other contraindication for MRI
- BMI ≥ 38.0 or maximum width less than 48 cm (necessary to fit within the MRI field of view)
Recruiting US locations
Dell Medical School Health Discovery Building
Austin, TX 78701
Site contact: Ingrid Harris, MPH · 5124710999 · ingrid.harris@austin.utexas.edu
Study contacts (from the official record)
- Jack Virostko, Ph.D. · 512-495-5126 · jack.virostko@austin.utexas.edu
- Ingrid Harris, MPH · 512-471-0999 · ingrid.harris@austin.utexas.edu
Similar studies in Texas
All diabetes studies in Texas →- RecruitingHealthy volunteersPhase 1
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
Gilead Sciences
- Location
- San Antonio, TX + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- San Antonio, TX + 3 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- Bellaire, TX + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1Overnight stay mentioned
MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
- Location
- Fredericksburg, TX
- Eligibility basics
- Ages 18–80